by David Kent | Aug 22, 2023
As an academic researcher in the blood stem cell field for the last 20 years, I’ve been involved in a large number of interdisciplinary collaborations and, more recently, a series of industry partnerships. There is no doubt in my mind that cell and gene therapy is one...
by Stephie Leung | Jul 20, 2023
A few months ago, I summarized seven local cell therapy companies in Canada that caught my attention. Since then, one full quarter of the financial calendar has passed. In the world of biotechnology start-ups, this could mean one more key milestone achieved, a new...
by Sara M. Nolte | Jun 21, 2023
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...
Comments